The duties of Board of Directors include supervising, guiding management echelon also to appoint and dismiss managers in order to ensure company’s normal operations and creating the best interests for all shareholders. The Board of Directors consists of 15 directors. All of the directors are selected by shareholders’ voting by nomination system. Directors have diverse professional background and extensive business experience, there are one female directors.
Director / James Chang, Ph.D.
CEO, TaiMed Biologics
Ph.D. degree in Chemical Engineering from of University of Washington, Seattle, USA.
Chairman of the Board / Lu-Ping Chow, Ph.D. ,
Representative of National Development Fund., Executive Yuan
Ph.D. degree in Pharmacy from Tokyo University of Science, Japan
Professor, The Institute of Biochemistry and Molecular Biology of National Taiwan University college of Medicine.
Chairman of the Board / Tai-Horng Young, Ph.D.
Representative of National Development Fund., Executive Yuan
Ph.D., Chemical Engineering, National Taiwan Univ.,
Professor, Institute of Biomedical Engineering, NTU,
Director / Lung-Yeh Cho, CPA
Mr. Cho is currently serving as Special Assistant to Chairman of Ruentex Group.
He received his Bachelor’s Degree in Accounting from National Taipei University, and passed the advanced-level civil service exam for international trade, and the certified public accounting exam.
Director / Tamon Tseng, LLM.
Mr. Tseng joined Ruentex Group in 1992, and is currently serving as Special Assistant to the CEO of Ruentex Industries, Ltd.
Mr. Tseng was called to the English Bar in 1985. He received a B.A. from the University of Cambridge, an LL.M. from University College London, and an LL.B. from National Chengchi University.
Director / Frank Chen
Representative of Chang Chun Investment, Ruentex Group
Master degree in Business Administration from National Taiwan University
Vice General Manager, Investment Management and Special Assistant to Chairman of Ruentex Group
Independent Director / Ming-Ching Chen, Ph.D.
Ph.D. degree in Accounting from Arizona State University, USA
Professor, Department of Accounting, National ChengChi University
Independent Director / Gwo-Fong Lin, Ph.D
Doctor of Philosophy in Engineering, University of Pittsburgh
Distinguished Professor, National Taiwan University
Corresponding Member, International Academy of Engineering, Russia
Independent Director / Howard S. Lee, Ph.D.
PhD in Chemistry, University of Southern California, USA
Partner, The CID Group
Chairman, Easywell Biomedicals, Inc.
Chairman, TAHO Pharmceuticals, Ltd.
Chairman, Transwell Biotech CO., Ltd.
1. Regulation for nomination and election
According to TaiMed’s Articles of
Incorporation, directors shall be elected pursuant to the candidates nomination
system as specified in Article 192-1 of the R.O.C. "Company Law".
(1) nomination system : According to the
Article 192-1 of the R.O.C. "Company Law", any shareholder holding 1%
or more of the total number of outstanding shares issued by the company may
submit to the company in writing a roster of director candidates
(2) elected number of independent directors：three in accordance with TaiMed’s Articles of Incorporation
(3) the period designated for accepting the
roster of director nominees : nomination system as specified in Article 192-1
of the R.O.C. "Company Law"。
(4) the place designated for accepting the
roster of director nominees : TaiMed Finance and Accounting Department (3F.,
No., 607, Ruiguang Rd., Neihu Dist., Taipei City 11492, Taiwan)
(5) documents submitted : The roster of
director candidates shall be annexed with the name, education background and
past work experience of the director candidates, the letter of understanding
issued by each director candidate to consent to act as director after he/she/it
has been elected as such, a written statement issued by each director candidate
assuring that he/she/it is not under any of the circumstances set forth in
Article 30 of this Act, and other evidential documents executed and provided by
each director candidate.
(6)professional qualification: the
candidates of independent director shall meet the
professional qualification requirements, shares
holding, etc set out in the “Regulations Governing Appointment of Independent
Directors and Compliance Matters for Public Companies”。
2. Election process for TaiMed’s Directors：
At the regular meeting of March 14, 2016, TaiMed’s
Board of Directors had approved a total of nine directors (including three
independent directors) to be elected at TaiMed's 2016 Annual Shareholders'
Meeting. The nomination time period set out from March 21 to March 31, 2016, and
TaiMed’s Board of Directors or any shareholder holding 1% or more of the total
number of outstanding shares issued by the company may submit to the company in
writing a roster of director candidates. All director nominees documents should
be sent to TaiMed Finance and Accounting Department (3F., No., 607, Ruiguang
Rd., Neihu Dist., Taipei City 11492, Taiwan) for review and approval.
At the meeting of Board of Directors of
April 20, 2016, it was reported that the Company received, during the
above-mentioned nomination period, the list of director/independent director
nominees sent from the Board of Directors. No nomination requests were received
from any qualified shareholder. Then the Board of Directors reviewed and
approved eight candidates for Board of Directors, including six Directors:
Frank Chen, Davis Liu, Lung-Yeh Cho, Dr. James Chang, Dr. Lu-Ping Chow , Dr. Ching-Chow
Chen; and three Independent Directors Dr. Ming-Ching Chen, Dr. Taychang Wang,
Dr. Jane Hsiao . These nine candidates for Board of Director will stand for
election at TaiMed's Annual General Meeting on June 2, 2016.
3. Election results for TaiMed’s Directors
TaiMed's 4th Board of Directors was elected
at TaiMed's 2016 Annual Shareholders' Meeting. The six elected directors are: Frank
Chen, Davis Liu, Lung-Yeh Cho, Dr. James Chang, Dr. Lu-Ping Chow , Dr.
Ching-Chow Chen. The three Independent Directors Dr. Ming-Ching Chen, Dr. Taychang
Wang, Dr. Jane Hsiao.
4. Change for Taimed Independent Director
Dr. Jane Hsiao proposed a resignation
for TaiMed’s Independent Director at January 1, 2017 due for her personal
reason. TaiMed will elect one Independent Director at TaiMed’s 2017 Annual
5. Election results for TaiMed’s new Independent Director